Last $6.55 USD
Change Today 0.00 / 0.00%
Volume 820.0
ICCC On Other Exchanges
As of 8:10 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

immucell corp (ICCC) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/26/15 - $6.86
52 Week Low
05/14/14 - $3.30
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IMMUCELL CORP (ICCC)

Related News

No related news articles were found.

immucell corp (ICCC) Related Businessweek News

No Related Businessweek News Found

immucell corp (ICCC) Details

ImmuCell Corporation develops, acquires, manufactures, and sells products that enhance animal health and productivity in the dairy and beef industries in the United States and internationally. The company offers First Defense, an orally delivered scours preventive product for newborn calves; Wipe Out Dairy Wipes, which consist of towelettes that are pre-moistened with a Nisin-based formulation to prepare the teat area of a cow in advance of milking; and California Mastitis Test that is used for bulk tank and individual cow sample monitoring, as well as to determine which quarter of the udder is mastitic. It is also involved in the development of Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows; and treatments that prevent calf scours caused by enteric pathogens in addition to E. coli K99 and bovine coronavirus. In addition, the company sells various product applications of its First Defense Technology, including a whey protein concentrate for the nutritional and feed supplement markets. ImmuCell Corporation sells its products to distributors and bovine veterinarians, as well as directly to producers. The company was founded in 1982 and is based in Portland, Maine.

32 Employees
Last Reported Date: 11/12/14
Founded in 1982

immucell corp (ICCC) Top Compensated Officers

Chief Executive Officer, President, Chief Fin...
Total Annual Compensation: $240.0K
Chief Scientific Officer, Vice President and ...
Total Annual Compensation: $140.0K
Director of Sales & Marketing
Total Annual Compensation: $164.4K
Compensation as of Fiscal Year 2013.

immucell corp (ICCC) Key Developments

ImmuCell Corporation Reports Unaudited Financial Results for the Third Quarter and Nine Months Ended September 30, 2014

ImmuCell Corporation reported unaudited financial results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported product sales was $1,770,000 against $1,235,000 a year ago. Net operating income was $41,000 against net operating loss of $160,000 a year ago. Income before income taxes was $30,000 against $77,000 a year ago. Net income was $10,000 or $0.00 per basic and diluted share against $57,000 or $0.02 per basic and diluted share a year ago. For the nine months, the company reported product sales of $5,392,000 against $4,448,000 a year ago. Net operating loss was $405,000 against net operating income of $190,000 a year ago. Loss before income taxes was $444,000 against income before income taxes of $458,000 a year ago. Net loss was $298,000 or $0.10 per basic and diluted share against net income of $268,000 or $0.09 per basic and diluted share a year ago.

ImmuCell Corp. Presents at LD Micro Conference, Dec-02-2014 05:30 PM

ImmuCell Corp. Presents at LD Micro Conference, Dec-02-2014 05:30 PM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California, United States. Speakers: Michael F. Brigham, Chief Executive Officer, President, Chief Financial Officer, Treasurer, Secretary and Director.

ImmuCell Corp. to Report Q3, 2014 Results on Nov 12, 2014

ImmuCell Corp. announced that they will report Q3, 2014 results at 5:00 PM, Eastern Standard Time on Nov 12, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICCC:US $6.55 USD 0.00

ICCC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Novartis AG SFr.88.85 CHF +1.85
Zoetis Inc $43.30 USD -0.79
View Industry Companies

Industry Analysis


Industry Average

Valuation ICCC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.9x
Price/Book 2.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUCELL CORP, please visit www.immucell.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.